Walleye Trading LLC Crispr Therapeutics Ag Put Options Transaction History

Walleye Trading LLC

$41.2 Billion
Q2 2024

Put Options

24 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $1.41 Million - $1.88 Million	-27,600 Reduced 73.8%	9,800 $529,000
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $4.6 Million - $6.76 Million	-75,900 Reduced 66.99%	37,400 $2.55 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $2.49 Million - $4.65 Million	64,400 Added 131.7%	113,300 $7.09 Million
Q3 2023 Nov 14, 2023	BUY	$45.39 - $59.0 $267,801 - $348,100	5,900 Added 13.72%	48,900 $2.22 Million
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $8.65 Million - $13.5 Million	-198,900 Reduced 82.22%	43,000 $2.41 Million
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $5.29 Million - $7.25 Million	129,100 Added 114.45%	241,900 $10.9 Million
Q4 2022 Feb 14, 2023	SELL	$39.19 - $65.67 $2.01 Million - $3.37 Million	-51,300 Reduced 31.26%	112,800 $4.59 Million
Q3 2022 Nov 14, 2022	SELL	$61.1 - $83.78 $30,550 - $41,890	-500 Reduced 0.3%	164,100 $10.7 Million
Q2 2022 Aug 08, 2022	BUY	$43.23 - $73.83 $2.93 Million - $5.01 Million	67,800 Added 70.04%	164,600 $10 Million
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $4.16 Million - $6.2 Million	78,300 Added 423.24%	96,800 $6.08 Million
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $42,054 - $66,774	-600 Reduced 3.14%	18,500 $1.4 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $253,460 - $360,271	2,300 Added 13.69%	19,100 $2.14 Million
Q2 2021 Aug 16, 2021	BUY	$100.84 - $161.89 $695,796 - $1.12 Million	6,900 Added 69.7%	16,800 $2.72 Million
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $409,664 - $777,148	3,700 Added 59.68%	9,900 $1.21 Million
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $470,053 - $1.02 Million	5,900 Added 1966.67%	6,200 $949,000
Q3 2020 Nov 16, 2020	SELL	$78.5 - $100.64 $78,500 - $100,640	-1,000 Reduced 76.92%	300 $25,000
Q2 2020 Aug 14, 2020	SELL	$38.5 - $76.05 $192,500 - $380,250	-5,000 Reduced 79.37%	1,300 $96,000
Q1 2020 May 15, 2020	SELL	$33.68 - $62.53 $1.63 Million - $3.02 Million	-48,300 Reduced 88.46%	6,300 $267,000
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $396,144 - $789,804	10,800 Added 24.66%	54,600 $3.33 Million
Q3 2019 Nov 14, 2019	BUY	$40.99 - $52.56 $1.77 Million - $2.28 Million	43,300 Added 8660.0%	43,800 $1.8 Million
Q2 2019 Aug 14, 2019	SELL	$35.45 - $48.2 $329,685 - $448,260	-9,300 Reduced 94.9%	500 $24,000
Q1 2019 May 15, 2019	SELL	$28.02 - $40.87 $439,914 - $641,659	-15,700 Reduced 61.57%	9,800 $350,000
Q4 2018 Feb 14, 2019	BUY	$22.73 - $42.34 $565,977 - $1.05 Million	24,900 Added 4150.0%	25,500 $729,000
Q3 2018 Nov 14, 2018	BUY	$44.35 - $65.71 $26,610 - $39,425	600 New	600 $27,000

Others Institutions Holding CRSP

# of Institutions

499

Shares Held

56.8M

Call Options Held

1.7M

Put Options Held

1.8M

Capital International Investors Los Angeles, CA

7.87M
Shares

$408 Million
0.09% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$389 Million
3.35% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$154 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$154 Million
1.61% of portfolio
Black Rock Inc. New York, NY

2.78M
Shares

$144 Million
0.0% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account